16S rRNA Sequencing Reveals Alterations of Gut Bacteria in Hirschsprung-Associated Enterocolitis

Abstract

Hirschsprung-associated enterocolitis (HAEC) stands as most common and serious complication of Hirschsprung's disease. Variations in the microbiota composition may account for the differences observed between HAEC and healthy individuals, offering crucial insights into the disease's pathogenesis. Here, we performed a study to changes in the gut microbiome using 16sRNA amplicon sequencing in a cohort of HAEC patients (n = 16) and healthy controls (n = 14). Our result revealed a significant disparity in beta diversity between the two groups. Following correction for false discovery rate, a rank-sum test at the genus level indicated a notable decrease in the relative abundance of Bifidobacterium, Lactobacillus, and Veillonella, whereas the Enterococcus genus exhibited a substantial increase in HAEC, a finding further supported by additional linear discriminant analysis effect size analysis. Functional analysis showed that putative transport and catabolism, digestive system, and metabolism of cofactors and vitamins were proved to be some abundant KOs (Kyoto Encyclopedia of Genes and Genomes [KEGG] orthologs) in healthy group, whereas infectious disease, membrane transport, and carbohydrate metabolism were the three KOs with the higher abundance in the HAEC group. Our data increased our insight into the HAEC, which may shed further light on HAEC pathogenesis. Our study firstly demonstrated the difference between fecal microbiota of HAEC patients and healthy individuals, which made a step forward in the understanding of the pathophysiology of HAEC.

Keywords

microbiota / diversity / metabolism / Enterococcus

References

[1] Austin KM. The pathogenesis of Hirschsprung's disease-associated enterocolitis. Semin Pediatr Surg 2012; 21(04) 319-327

[2] Ruttenstock E, Puri P. Systematic review and meta-analysis of enterocolitis after one-stage transanal pull-through procedure for Hirschsprung's disease. Pediatr Surg Int 2010; 26(11) 1101-1105

[3] Menezes M, Corbally M, Puri P. Long-term results of bowel function after treatment for Hirschsprung's disease: a 29-year review. Pediatr Surg Int 2006; 22(12) 987-990

[4] Galeano Niño JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 2022; 611(7937): 810-817

[5] Neuvonen MI, Korpela K, Kyrklund K, et al. Intestinal microbiota in Hirschsprung disease. J Pediatr Gastroenterol Nutr 2018; 67(05) 594-600

[6] Chantakhow S, Khorana J, Tepmalai K, Boonchooduang N, Chattipakorn N, Chattipakorn SC. Alterations of gut bacteria in Hirschsprung disease and Hirschsprung-associated enterocolitis. Microorganisms 2021; 9(11) 2241

[7] Gosain A. Established and emerging concepts in Hirschsprung's-associated enterocolitis. Pediatr Surg Int 2016; 32(04) 313-320

[8] Nakamura H, Tomuschat C, Coyle D, O'Donnel AM, Lim T, Puri P. Altered goblet cell function in Hirschsprung's disease. Pediatr Surg Int 2018; 34(02) 121-128

[9] Li H, Zhou L, Zhi Z, et al. Lipopolysaccharide upregulates miR-132/212 in Hirschsprung-associated enterocolitis, facilitating pyroptosis by activating NLRP3 inflammasome via targeting Sirtuin 1 (SIRT1). Aging (Albany NY) 2020; 12(18) 18588-18602

[10] Bachetti T, Rosamilia F, Bartolucci M, et al. The OSMR gene is involved in Hirschsprung associated enterocolitis susceptibility through an altered downstream signaling. Int J Mol Sci 2021; 22(08) 3831

[11] Arnaud AP, Cousin I, Schmitt F, et al. Different fecal microbiota in Hirschsprung's patients with and without associated enterocolitis. Front Microbiol 2022; 13: 904758

[12] Demehri FR, Frykman PK, Cheng Z, et al; HAEC Collaborative Research Group. Altered fecal short chain fatty acid composition in children with a history of Hirschsprung-associated enterocolitis. J Pediatr Surg 2016; 51(01) 81-86

[13] Parker KD, Mueller JL, Westfal M, Goldstein AM, Ward NL. A pilot study characterizing longitudinal changes in fecal microbiota of patients with Hirschsprung-associated enterocolitis. Pediatr Surg Int 2022; 38(11) 1541-1553

[14] Caporaso JG, Lauber CL, Walters WA, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 2012; 6(08) 1621-1624

[15] Rognes T, Flouri T, Nichols B, Quince C, Mahé F. VSEARCH: a versatile open source tool for metagenomics. PeerJ 2016; 4: e2584

[16] Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12(06) R60

[17] Langille MGI, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31(09) 814-821

[18] Dempsey E, Corr SC. Lactobacillus spp. for gastrointestinal health: current and future perspectives. Front Immunol 2022; 13: 840245

[19] Zhang W, Lyu M, Bessman NJ, et al; JRI Live Cell Bank. Gut-innervating nociceptors regulate the intestinal microbiota to promote tissue protection. Cell 2022; 185(22) 4170-4189.e20

[20] Chidambaram SB, Essa MM, Rathipriya AG, et al. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: tales of a vicious cycle. Pharmacol Ther 2022; 231: 107988

[21] Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis. Cancer Discovery. American Association for Cancer Research [Internet]. Accessed January 31, 2023 at: https://aacrjournals.org/cancerdiscovery/article-abstract/12/4/1128/689617/Cancer-Induces-a-Stress-Ileopathy-Depending-on?redirectedFrom=fulltext

[22] Lin B, Wang M, Gao R, et al. Characteristics of gut microbiota in patients with GH-secreting pituitary adenoma. Microbiol Spectr 2022; 10(01) e0042521

[23] García-Solache M, Rice LB. The enterococcus: a model of adaptability to its environment. Clin Microbiol Rev 2019; 32(02) e00058-e18

[24] Garrett WS. Enterococcus in graft-versus-host disease. N Engl J Med 2020; 382(11) 1064-1066

[25] Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 2018; 359(6380): 1156-1161

[26] Xiong X, Tian S, Yang P, et al. Emerging enterococcus pore-forming toxins with MHC/HLA-I as receptors. Cell 2022; 185(07) 1157-1171.e22

RIGHTS & PERMISSIONS

2024 Global Medical Genetics